| Name | 1-[4-(3-Fluoro-4-hydroxyphenyl)-1-piperazinyl]ethanone |
|---|---|
| Synonyms |
PKI 402
pound not PKI402 pound not PKI 402 1-[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-{4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}urea 1-[4-(3-fluoro-4-hydroxy-phenyl)-piperazin-1-yl]-ethanone |
| Molecular Formula | C12H15FN2O2 |
|---|---|
| Molecular Weight | 238.25800 |
| Exact Mass | 238.11200 |
| PSA | 43.78000 |
| LogP | 1.20270 |
|
~%
742067-12-5 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/69256 A1, 2004 ; Location in patent: Page/Page column 33 ; WO 2004/069256 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |